| Svetlana V Shifrin-douglas, MD | |
|
135 Route 35, Eatontown, NJ 07724-3766 | |
| (855) 660-4325 | |
| Not Available |
| Full Name | Svetlana V Shifrin-douglas |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 135 Route 35, Eatontown, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558329227 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jersey Shore University Medical Center | Neptune, NJ | Hospital |
| Riverview Medical Center | Red bank, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
News Archive
With more ethanol in production and a greater ability to upcycle co-products into animal feed ingredients, companies are creating custom products and partnering with University of Illinois researchers to test for quality and digestibility.
Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System demonstrated significantly better outcomes in key safety and efficacy measures compared to the TAXUS(R) Liberte Paclitaxel-Eluting Coronary Stent System (TAXUS).
Baxter International Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension of the therapeutic indications of KIOVIG to include a new indication for multifocal motor neuropathy (MMN), a severe, debilitating disorder requiring lifelong treatment.
T-System, Inc., the nation's largest provider of emergency department (ED) clinical documentation tools, today announced it has issued revised H1N1 point-of-care charting templates reflecting the most recent recommendations of the Centers for Disease Control and Prevention (CDC).
› Verified 4 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
With more ethanol in production and a greater ability to upcycle co-products into animal feed ingredients, companies are creating custom products and partnering with University of Illinois researchers to test for quality and digestibility.
Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System demonstrated significantly better outcomes in key safety and efficacy measures compared to the TAXUS(R) Liberte Paclitaxel-Eluting Coronary Stent System (TAXUS).
Baxter International Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension of the therapeutic indications of KIOVIG to include a new indication for multifocal motor neuropathy (MMN), a severe, debilitating disorder requiring lifelong treatment.
T-System, Inc., the nation's largest provider of emergency department (ED) clinical documentation tools, today announced it has issued revised H1N1 point-of-care charting templates reflecting the most recent recommendations of the Centers for Disease Control and Prevention (CDC).
› Verified 4 days ago
| Entity Name | Advocare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770538696 PECOS PAC ID: 3678562188 Enrollment ID: O20040510001217 |
News Archive
With more ethanol in production and a greater ability to upcycle co-products into animal feed ingredients, companies are creating custom products and partnering with University of Illinois researchers to test for quality and digestibility.
Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System demonstrated significantly better outcomes in key safety and efficacy measures compared to the TAXUS(R) Liberte Paclitaxel-Eluting Coronary Stent System (TAXUS).
Baxter International Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension of the therapeutic indications of KIOVIG to include a new indication for multifocal motor neuropathy (MMN), a severe, debilitating disorder requiring lifelong treatment.
T-System, Inc., the nation's largest provider of emergency department (ED) clinical documentation tools, today announced it has issued revised H1N1 point-of-care charting templates reflecting the most recent recommendations of the Centers for Disease Control and Prevention (CDC).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Svetlana V Shifrin-douglas, MD 135 Route 35, Eatontown, NJ 07724-3766 Ph: (848) 308-4924 | Svetlana V Shifrin-douglas, MD 135 Route 35, Eatontown, NJ 07724-3766 Ph: (855) 660-4325 |
News Archive
With more ethanol in production and a greater ability to upcycle co-products into animal feed ingredients, companies are creating custom products and partnering with University of Illinois researchers to test for quality and digestibility.
Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System demonstrated significantly better outcomes in key safety and efficacy measures compared to the TAXUS(R) Liberte Paclitaxel-Eluting Coronary Stent System (TAXUS).
Baxter International Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension of the therapeutic indications of KIOVIG to include a new indication for multifocal motor neuropathy (MMN), a severe, debilitating disorder requiring lifelong treatment.
T-System, Inc., the nation's largest provider of emergency department (ED) clinical documentation tools, today announced it has issued revised H1N1 point-of-care charting templates reflecting the most recent recommendations of the Centers for Disease Control and Prevention (CDC).
› Verified 4 days ago